Project Details
Layman's description
This study aim to calculate the minimal effective ropivacaine concentration required achieve successful analgesic interscalene block in 90% of patients (MEAC90).
Key findings
- Before induction of general anesthesia, all patients will receive interscalene block using 15ml of ropivacaine which concentration will be based on the response of the previous patient.
- Based on biased-coin design up-down sequential method: if patient has pain free recovery, a successful block, the next patient will be randomized to receive either the same ropivacaine concentration or a concentration 0.01% w/v less. However, if he has an unsuccessful block, the next patient will receive a concentration 0.01% w/v higher.
- Patients with pain free recovery will be considered to have positive response.
- Patients' responses will be analyzed to calculate the MEAC90.
- Based on biased-coin design up-down sequential method: if patient has pain free recovery, a successful block, the next patient will be randomized to receive either the same ropivacaine concentration or a concentration 0.01% w/v less. However, if he has an unsuccessful block, the next patient will receive a concentration 0.01% w/v higher.
- Patients with pain free recovery will be considered to have positive response.
- Patients' responses will be analyzed to calculate the MEAC90.
| Status | Finished |
|---|---|
| Effective start/end date | 1/05/21 → 30/09/21 |
Collaborative partners
- Healthpoint Hospital (lead)
- Abu Dhabi Health Services Company
Keywords
- Postoperative Complications
- Pathologic Processes
- Pain
- Neurologic Manifestations
- Postoperative Pain
- Local Anesthetics
- Anesthetics
- Central Nervous System Depressants
- Physiological Effects of Drugs
- Sensory System Agents
- Peripheral Nervous System Agents
- Ropivacaine
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.